Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 176
Filter
1.
Metab Eng ; 60: 25-36, 2020 07.
Article in English | MEDLINE | ID: mdl-32224264

ABSTRACT

Psilocybin is a tryptamine-derived psychoactive alkaloid found mainly in the fungal genus Psilocybe, among others, and is the active ingredient in so-called "magic mushrooms". Although its notoriety originates from its psychotropic properties and popular use as a recreational drug, clinical trials have recently recognized psilocybin as a promising candidate for the treatment of various psychological and neurological afflictions. In this work, we demonstrate the de novo biosynthetic production of psilocybin and related tryptamine derivatives in Saccharomyces cerevisiae by expression of a heterologous biosynthesis pathway sourced from Psilocybe cubensis. Additionally, we achieve improved product titers by supplementing the pathway with a novel cytochrome P450 reductase from P. cubensis. Further rational engineering resulted in a final production strain producing 627 ± 140 mg/L of psilocybin and 580 ± 276 mg/L of the dephosphorylated degradation product psilocin in triplicate controlled fed-batch fermentations in minimal synthetic media. Pathway intermediates baeocystin, nor norbaeocystin as well the dephosphorylated baeocystin degradation product norpsilocin were also detected in strains engineered for psilocybin production. We also demonstrate the biosynthetic production of natural tryptamine derivative aeruginascin as well as the production of a new-to-nature tryptamine derivative N-acetyl-4-hydroxytryptamine. These results lay the foundation for the biotechnological production of psilocybin in a controlled environment for pharmaceutical applications, and provide a starting point for the biosynthetic production of other tryptamine derivatives of therapeutic relevance.


Subject(s)
Metabolic Engineering/methods , Psilocybin/analogs & derivatives , Psilocybin/biosynthesis , Saccharomyces cerevisiae/metabolism , Tryptamines/biosynthesis , Escherichia coli/metabolism , Fermentation , NADPH-Ferrihemoprotein Reductase/biosynthesis , NADPH-Ferrihemoprotein Reductase/genetics , Psilocybe/genetics , Psilocybe/metabolism , Psilocybin/metabolism , Tryptophan/metabolism
2.
Can J Physiol Pharmacol ; 98(5): 267-274, 2020 May.
Article in English | MEDLINE | ID: mdl-31825663

ABSTRACT

Expression of NADPH - cytochrome P450 oxidoreductase (POR), electron donor for microsomal P450s, is induced in rat liver by dexamethasone (DEX), an activator of the glucocorticoid receptor (GR) and the pregnane X receptor (PXR). DEX induction of POR in rat liver is primarily PXR-mediated, although GR may contribute to mRNA effects. We examined the role of GR and PXR in the DEX induction of POR mRNA and protein in the H4IIE rat hepatoma cell line. The DEX EC50 for a PXR target, CYP3A23, exceeded that for the GR targets tyrosine aminotransferase and PXR as well as POR itself. POR protein levels were induced 3- and 4-fold, respectively, by DEX concentrations activating GR selectively (100 nM) or both GR and PXR (10 µM). POR was induced by triamcinolone acetonide, a selective GR agonist, but not pregnenolone-16α-carbonitrile, a selective PXR agonist. POR induction was blocked by the GR antagonist RU486 but minimally influenced by the PXR antagonist FLB-12. The half-life for POR mRNA was prolonged by DEX at both 100 nM and 10 µM. GR is more important in DEX-induced POR expression in H4IIE cells compared to rat liver in vivo, calling into question the suitability of this cell model for mechanistic studies.


Subject(s)
Carcinoma, Hepatocellular/pathology , Dexamethasone/pharmacology , Liver Neoplasms/pathology , NADPH-Ferrihemoprotein Reductase/biosynthesis , Animals , Cell Line, Tumor , Dose-Response Relationship, Drug , Enzyme Induction/drug effects , NADPH-Ferrihemoprotein Reductase/genetics , Pregnane X Receptor/metabolism , RNA, Messenger/genetics , Rats , Receptors, Glucocorticoid/metabolism
3.
Int J Cancer ; 144(3): 631-640, 2019 02 01.
Article in English | MEDLINE | ID: mdl-30110125

ABSTRACT

Prognostic and predictive biomarkers of disease and treatment outcome are needed to ensure optimal treatment of patients with triple-negative breast cancer (TNBC). In a mass spectrometry-based global proteomic study of 44 formalin-fixed, paraffin-embedded (FFPE) primary TNBC tumors and 10 corresponding metastases, we found that Cytochrome P450 reductase (CYPOR) expression correlated with patient outcome. The correlation between CYPOR expression and outcome was further evaluated in a Danish cohort of 113 TNBC patients using immunohistochemistry and publicly available gene expression data from two cohorts of TNBC and basal-like breast cancer patients, respectively (N = 249 and N = 580). A significant correlation between high CYPOR gene expression and shorter recurrence-free survival (RFS), but not overall survival, was found in the cohort of 249 TNBC patients (p = 0.018, HR = 1.77, 95% CI 1.1-2.85), and this correlation was recapitulated in a cohort of 580 basal-like breast cancer patients (p = 0.018, HR = 1.4, 95% CI 1.06-1.86). High CYPOR protein expression was also associated with shorter RFS in the cohort of 113 TNBC patients (p = 0.017, HR = 2.73, 95% CI 1.20-6.19), particularly those who were lymph node tumor-negative (p = 0.029, HR = 5.22). Multivariate Cox regression analysis identified CYPOR as an independent prognostic factor for shorter RFS in TNBC patients (p = 0.032, HR = 2.19, 95% CI 1.07-4.47). Together, these data suggest high expression of CYPOR as an independent prognostic biomarker of shorter RFS, which could be used to identify patients who should receive more extensive adjuvant treatment and more aggressive surveillance.


Subject(s)
Biomarkers, Tumor/biosynthesis , NADPH-Ferrihemoprotein Reductase/biosynthesis , Triple Negative Breast Neoplasms/enzymology , Biomarkers, Tumor/genetics , Cohort Studies , Disease-Free Survival , Female , Gene Expression , Humans , Immunohistochemistry , Lymph Nodes/pathology , Lymphatic Metastasis , Middle Aged , NADPH-Ferrihemoprotein Reductase/genetics , Neoplasm Recurrence, Local/enzymology , Neoplasm Recurrence, Local/pathology , Triple Negative Breast Neoplasms/genetics , Triple Negative Breast Neoplasms/pathology
4.
Sheng Wu Gong Cheng Xue Bao ; 34(7): 1156-1168, 2018 Jul 25.
Article in Chinese | MEDLINE | ID: mdl-30058314

ABSTRACT

Trametes versicolor has strong ability to degrade environmental organic pollutants. NADPH-cytochrome P450 reductase (CPR) of T. versicolor transfers electron to cytochrome P450s (CYPs) and participates in the degradation process of organic pollutants. Sequence analysis showed that the genome of T. versicolor contains 1 potential CPR and multiple potential CYP sequences. To further study the molecular mechanism for the involvement of T. versicolor CPR in the cellular degradation of organic pollutants, a CPR gene from T. versicolor was cloned and heterologously expressed in Escherichia coli. Subsequently, the main properties of the recombinant enzyme were investigated. A truncated CPR protein lacking the predicted membrane anchor region (residues 1-24), named CPRΔ24, was overexpressed as a soluble form in E. coli. The recombinant CPRΔ24 protein showed a molecular weight consistent with the theoretical value of 78 kDa. Recombinant CPRΔ24 was purified using a Ni²âº-chelating column followed by size exclusion chromatography. The specific activity of the purified CPRΔ24 was 5.82 U/mg. The CPRΔ24 enzyme displayed the maximum activity at 35 ℃ and pH 8.0. It has different degrees of tolerance against several types of metal ions and organic solvents. The apparent Km and kcat values of recombinant CPRΔ24 for NADPH were 19.7 µmol/L and 3.31/s, respectively, and those for the substrate cytochrome c were 25.9 µmol/L and 10.2/s, respectively, under conditions of 35 ℃ and pH 8.0. The above research provides the basis for exploring the functional mechanism of T. versicolor CPR in the degradation pathway of environmental organic pollutants.


Subject(s)
NADPH-Ferrihemoprotein Reductase/biosynthesis , Trametes/enzymology , Cloning, Molecular , Cytochrome P-450 Enzyme System , Escherichia coli , Fungal Proteins/biosynthesis , Industrial Microbiology , Recombinant Proteins/biosynthesis
5.
Drug Metab Dispos ; 45(2): 118-129, 2017 02.
Article in English | MEDLINE | ID: mdl-27856527

ABSTRACT

The aryl hydrocarbon receptor (AHR) nuclear translocator (ARNT), as the AHR's heterodimerization partner, and NADPH-cytochrome P450 oxidoreductase (POR), as the key electron donor for all microsomal P450s, are independent and indispensable components in the adaptive and toxic responses to polycyclic aromatic hydrocarbons. Expression of both ARNT and POR in rat liver is induced by dexamethasone (DEX), a synthetic glucocorticoid known to activate both the glucocorticoid receptor (GR) and the pregnane X receptor (PXR). To better understand the role of GR and PXR in the in vivo DEX induction of rat hepatic ARNT and POR at the mRNA and protein levels, we studied the following: 1) the effects of DEX doses that activate GR (≥0.1 mg/kg) or PXR (≥10 mg/kg); 2) responses produced by GR- and PXR-selective agonists; 3) the impact of GR antagonism on DEX's inducing effects; and 4) whether biologic responses to DEX are altered in PXR-knockout rats. Our findings are consistent with a role for GR as a key mediator of the induction of rat hepatic ARNT expression by glucocorticoids; a role for PXR in the modulation of ARNT protein levels could not be excluded. Although GR activation may contribute to POR mRNA induction, regulation of POR expression and function by DEX is primarily PXR-mediated. This work suggests that the hepatic expression and function of ARNT and POR may be modulated by exposure to exogenous PXR activators and/or conditions that alter glucocorticoid levels such as stress, steroidal therapies, and diseases of excess or deficiency.


Subject(s)
Aryl Hydrocarbon Receptor Nuclear Translocator/biosynthesis , Dexamethasone/pharmacology , Microsomes, Liver/drug effects , NADPH-Ferrihemoprotein Reductase/biosynthesis , Receptors, Glucocorticoid/physiology , Receptors, Steroid/physiology , Animals , Dose-Response Relationship, Drug , Enzyme Induction , Gene Knockout Techniques , Male , Microsomes, Liver/metabolism , Pregnane X Receptor , Rats, Inbred F344 , Rats, Sprague-Dawley , Receptors, Glucocorticoid/genetics , Receptors, Steroid/genetics
6.
Biotechnol Bioeng ; 113(6): 1225-33, 2016 06.
Article in English | MEDLINE | ID: mdl-26574191

ABSTRACT

New production routes for fine and bulk chemicals are important to establish further sustainable processes in industry. Besides the identification of new biocatalysts and new production routes the optimization of existing processes in regard to an improved utilization of the catalysts are needed. In this paper we describe the successful expression of P450BM3 on the surface of E. coli cells with the Autodisplay system. The successful hydroxylation of palmitic acid by using surface-displayed P450BM3 was shown. Besides optimization of surface protein expression, several cofactor regeneration systems were compared and evaluated. Afterwards, the development of a suitable process for the biocatalytic hydroxylation of fatty acids based on the re-use of the catalysts after a simple centrifugation was investigated. It was shown that the catalyst can be used for several times without any loss in activity. By using surface-displayed P450s in combination with an enzymatic cofactor regeneration system a total turnover number of up to 54,700 could be reached, to the knowledge of the authors the highest value reported for a P450 monooxygenase to date. Further optimizations of the described reaction system can have an enormous impact on the process design for more sustainable bioprocesses. Biotechnol. Bioeng. 2016;113: 1225-1233. © 2015 Wiley Periodicals, Inc.


Subject(s)
Bacterial Proteins/biosynthesis , Bacterial Proteins/chemistry , Cloning, Molecular/methods , Cytochrome P-450 Enzyme System/biosynthesis , Cytochrome P-450 Enzyme System/chemistry , Escherichia coli/enzymology , Escherichia coli/genetics , NADPH-Ferrihemoprotein Reductase/biosynthesis , NADPH-Ferrihemoprotein Reductase/chemistry , Protein Engineering/methods , Bacterial Proteins/genetics , Cytochrome P-450 Enzyme System/genetics , Hydrolysis , NADPH-Ferrihemoprotein Reductase/genetics , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
7.
PLoS One ; 10(8): e0135397, 2015.
Article in English | MEDLINE | ID: mdl-26252645

ABSTRACT

Camptothecin (CAM), a complex pentacyclic pyrroloqinoline alkaloid, is the starting material for CAM-type drugs that are well-known antitumor plant drugs. Although many chemical and biological research efforts have been performed to produce CAM, a few attempts have been made to uncover the enzymatic mechanism involved in the biosynthesis of CAM. Enzyme-catalyzed oxidoreduction reactions are ubiquitously presented in living organisms, especially in the biosynthetic pathway of most secondary metabolites such as CAM. Due to a lack of its reduction partner, most catalytic oxidation steps involved in the biosynthesis of CAM have not been established. In the present study, an NADPH-cytochrome P450 reductase (CPR) encoding gene CamCPR was cloned from Camptotheca acuminata, a CAM-producing plant. The full length of CamCPR cDNA contained an open reading frame of 2127-bp nucleotides, corresponding to 708-amino acid residues. CamCPR showed 70 ~ 85% identities to other characterized plant CPRs and it was categorized to the group II of CPRs on the basis of the results of multiple sequence alignment of the N-terminal hydrophobic regions. The intact and truncate CamCPRs with N- or C-terminal His6-tag were heterologously overexpressed in Escherichia coli. The recombinant enzymes showed NADPH-dependent reductase activity toward a chemical substrate ferricyanide and a protein substrate cytochrome c. The N-terminal His6-tagged CamCPR showed 18- ~ 30-fold reduction activity higher than the C-terminal His6-tagged CamCPR, which supported a reported conclusion, i.e., the last C-terminal tryptophan of CPRs plays an important role in the discrimination between NADPH and NADH. Co-expression of CamCPR and a P450 monooxygenase, CYP73A25, a cinnamate 4-hydroxylase from cotton, and the following catalytic formation of p-coumaric acid suggested that CamCPR transforms electrons from NADPH to the heme center of P450 to support its oxidation reaction. Quantitative real-time PCR analysis showed that CamCPR was expressed in the roots, stems, and leaves of C. acuminata seedlings. The relative transcript level of CamCPR in leaves was 2.2-fold higher than that of roots and the stems showed 1.5-fold transcript level higher than the roots. The functional characterization of CamCPR will be helpful to disclose the mysterious mechanisms of the biosynthesis of CAM. The present study established a platform to characterize the P450 enzymes involved in the growth, development, and metabolism of eukaryotic organisms.


Subject(s)
Camptotheca/genetics , Camptothecin/biosynthesis , NADPH-Ferrihemoprotein Reductase/genetics , Amino Acid Sequence , Antineoplastic Agents/chemistry , Camptotheca/enzymology , Catalysis , Cloning, Molecular , Cytochromes c/chemistry , DNA, Complementary/genetics , Escherichia coli/metabolism , Gene Expression Regulation, Plant , Models, Molecular , Molecular Conformation , Molecular Sequence Data , NADPH-Ferrihemoprotein Reductase/biosynthesis , Open Reading Frames , Phylogeny , Plant Leaves/metabolism , Plant Roots/metabolism , Plant Stems/metabolism , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Sequence Homology, Amino Acid , Tryptophan/chemistry
8.
FEBS Lett ; 588(6): 1001-7, 2014 Mar 18.
Article in English | MEDLINE | ID: mdl-24530525

ABSTRACT

(+)-Nootkatone is a natural sesquiterpene ketone used in grapefruit and citrus flavour compositions. It occurs in small amounts in grapefruit and is a major component of Alaska cedar (Callitropsis nootkatensis) heartwood essential oil. Upon co-expression of candidate cytochrome P450 enzymes from Alaska cedar in yeast with a valencene synthase, a C. nootkatensis valencene oxidase (CnVO) was identified to produce trans-nootkatol and (+)-nootkatone. Formation of (+)-nootkatone was detected at 144±10µg/L yeast culture. CnVO belongs to a new subfamily of the CYP706 family of cytochrome P450 oxidases.


Subject(s)
Cupressaceae/enzymology , NADPH-Ferrihemoprotein Reductase/chemistry , Plant Proteins/chemistry , Saccharomyces cerevisiae/enzymology , Cloning, Molecular , Cupressaceae/genetics , NADPH-Ferrihemoprotein Reductase/biosynthesis , NADPH-Ferrihemoprotein Reductase/genetics , Phylogeny , Plant Proteins/biosynthesis , Plant Proteins/genetics , Polycyclic Sesquiterpenes , Sesquiterpenes/metabolism , Substrate Specificity
9.
J Biol Chem ; 288(52): 37138-53, 2013 Dec 27.
Article in English | MEDLINE | ID: mdl-24196959

ABSTRACT

Hypoxia, a ubiquitous feature of tumors, can be exploited by hypoxia-activated prodrugs (HAP) that are substrates for one-electron reduction in the absence of oxygen. NADPH:cytochrome P450 oxidoreductase (POR) is considered one of the major enzymes responsible, based on studies using purified enzyme or forced overexpression in cell lines. To examine the role of POR in HAP activation at endogenous levels of expression, POR knock-outs were generated in HCT116 and SiHa cells by targeted mutation of exon 8 using zinc finger nucleases. Absolute quantitation by proteotypic peptide mass spectrometry of DNA sequence-confirmed multiallelic mutants demonstrated expression of proteins with residual one-electron reductase activity in some clones and identified two (Hko2 from HCT116 and S2ko1 from SiHa) that were functionally null by multiple criteria. Sensitivities of the clones to 11 HAP (six nitroaromatics, three benzotriazine N-oxides, and two quinones) were compared with wild-type and POR-overexpressing cells. All except the quinones were potentiated by POR overexpression. Knocking out POR had a marked effect on antiproliferative activity of the 5-nitroquinoline SN24349 in both genetic backgrounds after anoxic exposure but little or no effect on activity of most other HAP, including the clinical stage 2-nitroimidazole mustard TH-302, dinitrobenzamide mustard PR-104A, and benzotriazine N-oxide SN30000. Clonogenic cell killing and reductive metabolism of PR-104A and SN30000 under anoxia also showed little change in the POR knock-outs. Thus, although POR expression is a potential biomarker of sensitivity to some HAP, identification of other one-electron reductases responsible for HAP activation is needed for their rational clinical development.


Subject(s)
Antineoplastic Agents/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Gene Expression Regulation, Neoplastic/drug effects , NADPH-Ferrihemoprotein Reductase/biosynthesis , Neoplasm Proteins/biosynthesis , Neoplasms/drug therapy , Prodrugs/pharmacology , Antineoplastic Agents/pharmacokinetics , Cell Hypoxia/drug effects , Cell Hypoxia/genetics , Cell Line, Tumor , Drug Screening Assays, Antitumor , Gene Expression Regulation, Enzymologic/genetics , Gene Expression Regulation, Neoplastic/genetics , Gene Knockdown Techniques , Humans , NADPH-Ferrihemoprotein Reductase/genetics , Neoplasm Proteins/genetics , Neoplasms/enzymology , Neoplasms/genetics , Neoplasms/pathology , Prodrugs/pharmacokinetics
10.
J Oleo Sci ; 62(5): 293-6, 2013.
Article in English | MEDLINE | ID: mdl-23648403

ABSTRACT

In this study, biotransformation of (+)-fenchone (compound 1) by Salmonella typhimurium OY1002/2A6 expressing human CYP2A6 and NADPH-P450 reductase yielded two oxidized metabolites, namely, (+)-(1S,6R)-6-endo-hydroxyfenchone (compound 2) and (+)-(1S,6S)-6-exo-hydroxyfenchone (compound 3). The conversion rate of compound 1 to compound 2 and 3 was 2.4% and 5.2%, respectively. This is the first study that succeeded in metabolizing compound 1 to obtain large amounts of metabolite 2 and 3 by using S. typhimurium OY1002/2A6 expressing human CYP2A6 and NADPH-P450 reductase.


Subject(s)
Aryl Hydrocarbon Hydroxylases/biosynthesis , NADPH-Ferrihemoprotein Reductase/biosynthesis , Norbornanes/metabolism , Salmonella typhimurium/enzymology , Aryl Hydrocarbon Hydroxylases/genetics , Biotransformation , Camphanes , Cytochrome P-450 CYP2A6 , Humans , NADPH-Ferrihemoprotein Reductase/genetics , Salmonella typhimurium/genetics
11.
Methods Mol Biol ; 987: 225-37, 2013.
Article in English | MEDLINE | ID: mdl-23475681

ABSTRACT

P450 oxidoreductase (POR) is the flavoprotein that transfers electrons from NADPH to microsomal cytochrome P450 enzymes and to some other proteins. Protocols for genotyping human POR for common polymorphisms are described. Expression in E. coli of recombinant human POR, its purification, and different methods of assessing the effect of amino-acid sequence variants of POR on the activity of various cytochromes P450 are also described.


Subject(s)
Enzyme Assays/methods , Genotyping Techniques , Mutation , NADPH-Ferrihemoprotein Reductase/genetics , NADPH-Ferrihemoprotein Reductase/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Cell Membrane/genetics , DNA/blood , DNA/genetics , Escherichia coli/cytology , Escherichia coli/genetics , Gene Expression , Humans , Microsomes/enzymology , NADPH-Ferrihemoprotein Reductase/biosynthesis , NADPH-Ferrihemoprotein Reductase/isolation & purification , Nickel/chemistry , Polymerase Chain Reaction , Recombinant Proteins/biosynthesis , Recombinant Proteins/isolation & purification
12.
Zhejiang Da Xue Xue Bao Yi Xue Ban ; 42(1): 38-44, 2013 01.
Article in Chinese | MEDLINE | ID: mdl-23505106

ABSTRACT

OBJECTIVE: To investigate the optimal conditions of tri-expression of CYP3A4, POR and cyt b5 in Sf 9 cells. METHODS: The Sf 9 cells expressing CYP3A4, POR and cyt b5 were cultured in shaker flasks. The optimized conditions, including the temperature and rotation speed, the culture volume, the amount of surfactant and the culture time were studied. The expressed products in microsomes were used to metabolize the testosterone and their metabolic activity was determined. RESULTS: When the temperature and rotation speed of the shaker were 27 degree and 90 r/min, the cell density and culture volume were 5X105 cells/ml and 80-120 ml per 250 ml shaker flasks, respectively. When Pluronic F-68 was 0.1% and the culture time was 72 h, the condition was most suitable for culture of Sf 9 cells and expression of targeted proteins. When the ratio of the volume of three added viruses was 1:1:1, the expression condition was optimal, under which the Km, Vmax, and CLint for testosterone metabolism were 119.6 µmol/L,0.52 µmol/(min*g protein) and 4.34 ml/(min*g protein), respectively. CONCLUSION: The conditions of tri-expressing of CYP3A4, POR and cyt b5 have been optimized in the study and the product CYP3A4 is obtained with higher metabolic activity.


Subject(s)
Cytochrome P-450 CYP3A/biosynthesis , Cytochromes b5/biosynthesis , NADPH-Ferrihemoprotein Reductase/biosynthesis , Animals , Humans , Insecta , Sf9 Cells
13.
Methods Mol Biol ; 995: 193-205, 2013.
Article in English | MEDLINE | ID: mdl-23494381

ABSTRACT

The production of contrast agents sensitive to neuronal signaling events is a rate-limiting step in the development of molecular-level functional magnetic resonance imaging (molecular fMRI) approaches for studying the brain. High-throughput generation and evaluation of potential probes are possible using techniques for macromolecular engineering of protein-based contrast agents. In an initial exploration of this strategy, we used the method of directed evolution to identify mutants of a bacterial heme protein that allowed detection of the neurotransmitter dopamine in vitro and in living animals. The directed evolution method involves successive cycles of mutagenesis and screening that could be generalized to produce contrast agents sensitive to a variety of molecular targets in the nervous system.


Subject(s)
Biosensing Techniques/methods , Directed Molecular Evolution/methods , Magnetic Resonance Imaging , Bacterial Proteins/biosynthesis , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Contrast Media/chemistry , Cytochrome P-450 Enzyme System/biosynthesis , Cytochrome P-450 Enzyme System/chemistry , Cytochrome P-450 Enzyme System/genetics , Dopamine/chemistry , Escherichia coli , Gene Library , Heme/biosynthesis , Heme/chemistry , High-Throughput Screening Assays , NADPH-Ferrihemoprotein Reductase/biosynthesis , NADPH-Ferrihemoprotein Reductase/chemistry , NADPH-Ferrihemoprotein Reductase/genetics , Neurotransmitter Agents/chemistry , Polymerase Chain Reaction , Protein Binding , Protein Engineering/methods , Titrimetry
14.
Can J Physiol Pharmacol ; 90(10): 1354-63, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22978700

ABSTRACT

The aryl hydrocarbon receptor (AHR) has physiological roles in the absence of exposure to exogenous ligands, and mediates adaptive and toxic responses to the environmental pollutant 2,3,7,8-tetracholorodibenzo-p-dioxin (TCDD). A readily metabolized AHR agonist, 3-methylcholanthrene, disrupts the expression of mouse hepatic growth hormone (GH) signaling components and suppresses cytochrome P450 2D9 (Cyp2d9), a male-specific gene controlled by pulsatile GH via signal transducer and activator of transcription 5b (STAT5b). Using TCDD as an essentially nonmetabolized AHR agonist, and Ahr (-/-) mice as the preferred model to determine the AHR-dependence of biological responses, we now show that 2 mouse hepatic STAT5b target genes, Cyp2d9, and major urinary protein 2 (Mup2), are suppressed by TCDD in an AHR-dependent manner. TCDD also decreased hepatic mRNA levels for GH receptor, Janus kinase 2, and STAT5a/b with AHR-dependence. Without inducing selected hepatic inflammatory markers, TCDD caused AHR-dependent induction of Cyp1a1 and NADPH-cytochrome P450 oxidoreductase (Por) and suppression of Cyp3a11. In vehicle-treated mice, basal mRNA levels for CYP2D9, CYP3A11, POR, serum amyloid protein P, and MUP2 were influenced by Ahr genetic status. We conclude that AHR activation per se leads to dysregulation of hepatic GH signaling components and suppression of some, but not all, STAT5b target genes.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/agonists , Cytochrome P-450 Enzyme System/metabolism , Environmental Pollutants/toxicity , Liver/drug effects , Polychlorinated Dibenzodioxins/toxicity , Receptors, Aryl Hydrocarbon/agonists , Receptors, Somatotropin/metabolism , Signal Transduction/drug effects , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Basic Helix-Loop-Helix Transcription Factors/metabolism , Cytochrome P-450 CYP1A1/biosynthesis , Cytochrome P-450 CYP1A1/genetics , Cytochrome P-450 CYP3A/genetics , Cytochrome P-450 CYP3A/metabolism , Cytochrome P-450 CYP3A Inhibitors , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Enzyme System/genetics , Cytochrome P450 Family 2 , Down-Regulation/drug effects , Environmental Pollutants/administration & dosage , Enzyme Induction/drug effects , Janus Kinase 2/antagonists & inhibitors , Janus Kinase 2/genetics , Janus Kinase 2/metabolism , Liver/immunology , Liver/metabolism , Male , Membrane Proteins/antagonists & inhibitors , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , NADPH-Ferrihemoprotein Reductase/biosynthesis , NADPH-Ferrihemoprotein Reductase/genetics , Polychlorinated Dibenzodioxins/administration & dosage , Proteins/antagonists & inhibitors , Proteins/genetics , Proteins/metabolism , RNA, Messenger/metabolism , Receptors, Aryl Hydrocarbon/genetics , Receptors, Aryl Hydrocarbon/metabolism , Receptors, Somatotropin/antagonists & inhibitors , Receptors, Somatotropin/genetics , STAT5 Transcription Factor/antagonists & inhibitors , STAT5 Transcription Factor/genetics , STAT5 Transcription Factor/metabolism
15.
Biochem J ; 432(3): 485-93, 2010 Dec 15.
Article in English | MEDLINE | ID: mdl-20879989

ABSTRACT

We have incorporated CYP3A4 (cytochrome P450 3A4) and CPR (NADPH-cytochrome P450 reductase) into liposomes with a high lipid/protein ratio by an improved method. In the purified proteoliposomes, CYP3A4 binds testosterone with Kd (app)=36±6 µM and Hill coefficient=1.5±0.3, and 75±4% of the CYP3A4 can be reduced by NADPH in the presence of testosterone. Transfer of the first electron from CPR to CYP3A4 was measured by stopped-flow, trapping the reduced CYP3A4 as its Fe(II)-CO complex and measuring the characteristic absorbance change. Rapid electron transfer is observed in the presence of testosterone, with the fast phase, representing 90% of the total absorbance change, having a rate of 14±2 s(-1). Measurements of the first electron transfer were performed at various molar ratios of CPR/CYP3A4 in proteoliposomes; the rate was unaffected, consistent with a model in which first electron transfer takes place within a relatively stable CPR-CYP3A4 complex. Steady-state rates of NADPH oxidation and of 6ß-hydroxytestosterone formation were also measured as a function of the molar ratio of CPR/CYP3A4 in the proteoliposomes. These rates increased with increasing CPR/CYP3A4 ratio, showing a hyperbolic dependency indicating a Kd (app) of ~0.4 µM. This suggests that the CPR-CYP3A4 complex can dissociate and reform between the first and second electron transfers.


Subject(s)
Biocatalysis , Cytochrome P-450 CYP3A/metabolism , NADPH-Ferrihemoprotein Reductase/metabolism , Cytochrome P-450 CYP3A/biosynthesis , Cytochrome P-450 CYP3A/isolation & purification , Electron Transport , Humans , Hydroxylation , Hydroxytestosterones/metabolism , Kinetics , Liposomes , Models, Molecular , NADP/metabolism , NADPH-Ferrihemoprotein Reductase/biosynthesis , NADPH-Ferrihemoprotein Reductase/isolation & purification , Phosphatidic Acids , Phosphatidylcholines , Protein Binding , Recombinant Proteins/biosynthesis , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Testosterone/metabolism
16.
Drug Metab Lett ; 4(4): 246-53, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20722625

ABSTRACT

Cytochrome P450 (CYP450) isozymes play an important role in the study of drug metabolism and drug discovery. A number of reports are available that describe recombinant expression of CYP450 isozymes. In this paper, human CYP2C9 and human cytochrome P450 reductase cDNAs were cloned and expressed in Premas proprietary yeast episomal and integrative vectors respectively under the influence of GAL1 promoter. Yeast cells were grown and induced at optimal parameters to make microsomal membranes. Isolated microsomal membranes were analyzed for CYP2C9 and cytochrome P450 reductase activity, CYP2C9 content and inhibition properties. We report heterologous expression of human CYP2C9 along with human cytochrome P450 reductase in protease deficient S. cerevisiae at a 5 litre scale resulting in high yields (8-10 nmols/litre) of enzyme with higher specific activity (2-3 fold higher). This yields a superior enzyme and makes it amenable to miniaturization of screening assays with concomitant lowering of costs.


Subject(s)
Aryl Hydrocarbon Hydroxylases/metabolism , NADPH-Ferrihemoprotein Reductase/metabolism , Peptide Hydrolases/deficiency , Saccharomyces cerevisiae/enzymology , Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors , Aryl Hydrocarbon Hydroxylases/biosynthesis , Aryl Hydrocarbon Hydroxylases/genetics , Cytochrome P-450 CYP2C9 , Cytochromes b5/genetics , Cytochromes b5/metabolism , Fluorescein/metabolism , Humans , Kinetics , Microsomes/enzymology , NADPH-Ferrihemoprotein Reductase/biosynthesis , NADPH-Ferrihemoprotein Reductase/genetics , Peptide Hydrolases/genetics , Recombinant Proteins/metabolism , Saccharomyces cerevisiae/genetics , Substrate Specificity , Sulfaphenazole/pharmacology
17.
Drug Metab Dispos ; 38(7): 1015-8, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20382755

ABSTRACT

Dog CYP2A13 and CYP2A25 were coexpressed with dog NADPH-cytochrome P450 reductase (OR) in baculovirus-infected Sf9 insect cells. CYP2A13 effectively catalyzed 7-ethoxycoumarin (7EC) deethylation and coumarin hydroxylation with apparent K(m) values of 4.8 and 2.1 microM, respectively, similar to those observed using dog liver microsomes (7.5 and 0.75 microM, respectively). CYP2A25 exhibited much lower affinity toward 7EC, with an apparent K(m) value of 150 microM, which indicates that CYP2A13 plays a more significant role in the metabolism of these CYP2A substrates. Similar to the dog CYP1A2 enzyme, CYP2A13 efficiently catalyzed phenacetin deethylation with a K(m) value of 3.9 microM, which suggests that phenacetin is not a selective probe for dog CYP1A2 activity. Both dog CYP2A13 and CYP2A25 exhibited little or no catalytic activity toward other common cytochrome P450 probe substrates, including bupropion, amodiaquine, diclofenac, S-mephenytoin, bufuralol, dextromethorphan, midazolam, and testosterone. These results provided additional information about the selectivity of these commonly used probe substrates.


Subject(s)
Cytochrome P-450 Enzyme System/genetics , Cytochrome P-450 Enzyme System/metabolism , Gene Expression Regulation, Enzymologic , Animals , Baculoviridae/metabolism , Cells, Cultured , Coumarins/metabolism , Dogs , Microsomes, Liver/enzymology , NADPH-Ferrihemoprotein Reductase/biosynthesis , Phenacetin/metabolism , Spodoptera/genetics , Spodoptera/virology , Substrate Specificity
18.
J Pharmacol Exp Ther ; 334(1): 156-63, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20400470

ABSTRACT

An intestinal epithelium-specific cytochrome P450 (P450) reductase (CPR)-knockout (IE-Cpr-null) mouse and a liver-specific CPR-knockout (liver-Cpr-null) mouse were studied for determination of the respective roles of P450 enzymes in the liver and small intestine (SI) in the clearance of orally administered benzo[a]pyrene (BaP). Pharmacokinetic analysis of blood BaP levels indicated significantly lower rates of BaP clearance in IE-Cpr-null than in wild-type (WT) mice, after oral BaP (30 mg/kg) treatment. In contrast, clearance rates for intraperitoneal BaP (45 mg/kg) were not different between IE-Cpr-null and WT mice. Furthermore, there was no significant difference between liver-Cpr-null and WT mice in BaP clearance, after either intraperitoneal or oral BaP administration. Thus, small-intestinal P450-mediated first-pass metabolism is a key determinant of the systemic bioavailability of oral BaP. In addition, we observed greater differences in the rates of clearance of oral BaP, between WT and IE-Cpr-null mice, in mice pretreated with beta-naphthoflavone, to induce CYP1A1 expression, than in untreated mice. The onset of induction (at 2 h after dosing) of CYP1A1 protein expression by oral BaP administration was earlier in the SI than in extra-gut organs analyzed; for liver, lung, and kidney, induction was not observed until 4 h after dosing. Furthermore, BaP tissue burdens in SI and extra-gut organs of IE-Cpr-null mice were greater than burdens in corresponding organs of WT mice, at 6 or 24 h after BaP administration. Taken together, these findings strongly support the concept that small-intestinal CYP1A1 induction is a critical factor in protection against systemic exposure to oral BaP.


Subject(s)
Benzo(a)pyrene/pharmacokinetics , Intestinal Mucosa/enzymology , Intestine, Small/enzymology , NADPH-Ferrihemoprotein Reductase/physiology , Administration, Oral , Animals , Benzo(a)pyrene/administration & dosage , Benzo(a)pyrene/toxicity , Intestinal Mucosa/drug effects , Intestine, Small/drug effects , Kidney/drug effects , Kidney/enzymology , Liver/drug effects , Liver/enzymology , Lung/drug effects , Lung/enzymology , Male , Metabolic Clearance Rate , Mice , Mice, Inbred C57BL , Mice, Knockout , Microsomes/drug effects , Microsomes/enzymology , NADPH-Ferrihemoprotein Reductase/biosynthesis , NADPH-Ferrihemoprotein Reductase/genetics , Tissue Distribution
19.
J Pharmacol Exp Ther ; 334(1): 69-77, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20375200

ABSTRACT

A mouse model termed Cpr-low (CL) was recently generated, in which the expression of the cytochrome P450 reductase (Cpr) gene was globally down-regulated. The decreased CPR expression was accompanied by phenotypical changes, including reduced embryonic survival, decreases in circulating cholesterol, increases in hepatic P450 expression, and female infertility (accompanied by elevated serum testosterone and progesterone levels). In the present study, a complementary mouse model [named reversible-CL (r-CL)] was generated, in which the reduced CPR expression can be reversed in an organ-specific fashion. The neo cassette, which was inserted into the last Cpr intron in r-CL mice, can be deleted by Cre recombinase, thus returning the structure of the Cpr gene (and hence CPR expression) to normal in Cre-expressing cells. All previously identified phenotypes of the CL mice were preserved in the r-CL mice. As a first application of the r-CL model, we have generated an extrahepatic-CL (xh-CL) mouse for testing of the functions of CPR-dependent enzymes in all extrahepatic tissues. The xh-CL mice, generated by mating of r-CL mice with albumin-Cre mice, had normal CPR expression in hepatocytes but down-regulated CPR expression elsewhere. They were indistinguishable from wild-type mice in body and liver weights, circulating cholesterol levels, and hepatic microsomal P450 expression and activities; however, they still showed elevated serum testosterone and progesterone levels and sterility in females. Embryonic lethality was prevented in males, but apparently not in females, indicating a critical role for fetal hepatic CPR-dependent enzymes in embryonic development, at least in males.


Subject(s)
Liver/enzymology , Models, Animal , NADPH-Ferrihemoprotein Reductase/genetics , NADPH-Ferrihemoprotein Reductase/physiology , Animals , Body Weight , Cholesterol/blood , Embryo Loss/enzymology , Embryo Loss/genetics , Female , Fetal Development/genetics , Hepatocytes/enzymology , Infertility, Female/enzymology , Infertility, Female/genetics , Liver/embryology , Male , Mice , Mice, Inbred Strains , Microsomes, Liver/enzymology , NADPH-Ferrihemoprotein Reductase/biosynthesis , Organ Size , Organ Specificity , Progesterone/blood , Sex Characteristics , Testosterone/blood , Xenobiotics/metabolism , Xenobiotics/pharmacokinetics
20.
J Biochem ; 147(3): 433-43, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19910312

ABSTRACT

Two-cistronic expression plasmids are useful for high-level expression of heterologous genes in Escherichia coli cells by preventing the inhibition of translational initiation. In the process of constructing a two-cistronic expression plasmid pCbSTCR-4 containing the fragments of the porcine cytochrome b(5) (Psb5) and NADPH-cytochrome P450 reductase (PsCPR) genes as the first and second cistrons, respectively, the presence of a specific region in the first cistron that lowered the accumulation level of the PsCPR was suggested [Kimura, S., et al. (2005) J. Biochem. 137, 523-533]. In this study, a disturbing nucleotide sequence similar to a Shine-Dalgarno (SD) sequence (SD-like sequence), AGGAG, was identified at the 5'-upstream region near the SD sequence for the second cistron. Silent mutations in the SD-like sequence that lowered the similarity to a typical SD sequence increased the accumulation level of PsCPR. SD-like sequences introduced into mono-cistronic expression plasmids for the Psb5 and PsCPR genes also decreased the accumulation level of these proteins. The SD-like sequence also decreased the accumulation level of the insoluble PsCPR protein. This type of ribosome-binding site interference is useful not only for precise control of protein accumulation but also for increasing the soluble form of recombinant proteins in E. coli cells.


Subject(s)
Escherichia coli/metabolism , Regulatory Sequences, Nucleic Acid , Ribosomes/metabolism , Animals , Binding Sites/genetics , Cytochromes b5/biosynthesis , Cytochromes b5/genetics , DNA/genetics , DNA/metabolism , Gene Expression Regulation , Molecular Sequence Data , Mutagenesis, Site-Directed , NADPH-Ferrihemoprotein Reductase/biosynthesis , NADPH-Ferrihemoprotein Reductase/genetics , Plasmids/genetics , Protein Biosynthesis , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...